A carregar...
Nivolumab monotherapy in recurrent metastatic urothelial carcinoma (CheckMate 032): a multicentre, open-label, phase 1/2 trial
BACKGROUND: There are few effective treatments for advanced urothelial carcinoma after progression following platinum-based chemotherapy. We assessed the activity and safety of nivolumab in patients with locally advanced or metastatic urothelial carcinoma who progressed after prior platinum-based th...
Na minha lista:
| Publicado no: | Lancet Oncol |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5648054/ https://ncbi.nlm.nih.gov/pubmed/27733243 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S1470-2045(16)30496-X |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|